Protech Announces Execution of LOI to Acquire a Profitable Leading Supplier of Respiratory Therapy Products and Services in the Southeastern U.S.

    NEXT STORY
    CB2 to Host Virtual Annual General Meeting on September 9, 2020
    PREV STORY
    Innovation Pharmaceuticals Announces Publication of Independent Research on Kevetrin, the Company’s p53 Drug Candidate, in Oncology Reports
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Global Personal Care Wipes Market (2020 to 2025) – Featuring Unicharm, Suominen & Rockline Among Others

    author_avatar
    NASDAQ Market News

    VBL Therapeutics Presents Results from Phase 3 GLOBE Study in Patients with Recurrent Glioblastoma at the 2018 Society for Neuro-Oncology Annual Meeting

    Additional Analyses Provide Insight into Treatment Effect of VB-111 TEL AVIV, Israel, Nov. 16, ...

    author_avatar
    NASDAQ Market News

    ContraFect to Present at JMP Securities Life Sciences Conference

    YONKERS, N.Y., June 14, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology ...

    author_avatar
    NASDAQ Market News